関連する実験動画
Updated: Sep 9, 2025

09:42
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
Published on: June 4, 2021
2.9K
新発症性全身性白血病における血栓塞栓症および抗リン脂症症候群の蓄積:集団ベースの初期コホート研究
Sigrid Reppe Moe1,2, Hilde Haukeland3,2,4, Cathrine Brunborg5
1Department of Rheumatology, Oslo University Hospital, Oslo, Norway sigrid@repmoe.no.
RMD open
|September 3, 2025
まとめ
新規に診断された全身性白血球症 (SLE) 患者,特にアンチフォスフォリピド抗体 (aPL) を有する患者は,高血栓塞栓症 (TE) のリスクに直面します. 早期の予防戦略は,早期のSLEにおけるこの高いTEリスクの管理に不可欠です.
科学分野:
- リウマトロジ
- 免疫学
- 血管医学
背景:
- システム性白血球症 (SLE) は慢性的な自己免疫疾患で,血栓塞栓症 (TE) のリスクが高まります.
- 抗リンパ脂症症候群 (APS) と抗リンパ脂抗体 (aPL) は,SLE患者における TEの危険因子として知られています.
- SLE発症のタイミングと発生率を理解することは,リスクの階層化と管理に不可欠です.
研究 の 目的:
- 血栓塞栓症 (TE) と抗リンパ脂症症候群 (APS) の発症時期と発症率を決定する.
- TE,APS,および抗フォスホリピド抗体 (aPL) の間の関係を患者フォローアップで評価する.
- 新しく診断されたSLEにおける TEのリスクの高い患者グループを特定する.
主な方法:
- ノルウェー南東部の新発症SLE患者 (2000年−2017年) を含む人口ベースのコホート研究
- 分類基準:SLEの2019年EULAR/ACR,APSの2006年シドニー
- 評価された結果:APS,TE,死亡 生存分析に使用されたカプラン・マイヤー法.
主要な成果:
- 700人のSLE患者の13%が,平均8年間の追跡期間中に新しいTEを発症しました.
- TEの発生率は,SLEの診断後の最初の年にピークに達し,特にaPL陽性APS患者 (100人当たり59人) であった.
- APSのない患者とaPL陰性患者,特に50歳未満の患者では,TEの発生率が著しく低かった.
結論:
- 新規にSLEと診断された患者,特にaPL陽性患者は,診断の時点でTEのリスクが高くなります.
- この研究は,新たに診断されたSLE患者における TEの早期発見と予防戦略の必要性を強調しています.
- aPL 状態と APS 診断に基づくリスクの階層化は,SLEにおける TEの管理に不可欠です.
関連する概念動画
Venous Thrombosis I: Introduction
40
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
40
Anticoagulant Drugs: Low-Molecular-Weight Heparins
889
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
889
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
34
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
34
Disorders of Hemostasis
1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Endocarditis II: Clinical Features of Infective Endocarditis
25
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
25

